26 November 2024

Starpharma to present at OTCQX Virtual Investor Conference

 

Melbourne, Australia; 18 June 2020: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that a pre-recorded presentation by Dr Jackie Fairley, CEO, will be broadcast on Thursday 18 June 2020 (US ET) as part of OTCQX’s Virtual Investor Conference for Global Mid-cap and Large-cap Companies. The conference is primarily attended  by US-based  retail investors, as well as advisors.

Details of the conference are found via www.VirtualInvestorConferences.com. The presentation will feature an overview of Starpharma’s business for new investors, including the Company’s COVID-19 antiviral product and recent highlights from the VivaGel® and DEP® portfolios. The presentation was recorded prior to the DEP® lutetium announcement on 17 June 2020 and will be available on Starpharma’s website. 

The slide presentation is available here (pdf file, 3MB)

Download ASX Announcement: Starpharma to present at OTCQX Virtual Investor Conference (pdf file, 44kb)

This contains certain forward-looking statements.

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.